OpGen Inc. (NASDAQ: OPGN)
$3.21
+0.1500 ( +4.90% ) 5.2K
OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.
Market Data
Open
$3.21
Previous close
$3.06
Volume
5.2K
Market cap
$4.16M
Day range
$3.08 - $3.34
52 week range
$1.65 - $38.40
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 2 | Apr 26, 2024 |
4 | Insider transactions | 1 | Apr 25, 2024 |
8-k | 8K-related | 15 | Apr 25, 2024 |
8-k | 8K-related | 15 | Apr 23, 2024 |
8-k | 8K-related | 14 | Apr 17, 2024 |
pre | Proxies and info statements | 2 | Apr 16, 2024 |
4 | Insider transactions | 1 | Apr 15, 2024 |
4 | Insider transactions | 1 | Apr 12, 2024 |
4 | Insider transactions | 1 | Apr 12, 2024 |
4 | Insider transactions | 1 | Apr 12, 2024 |